CRISPR Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

13.02.24	CRISPR Therapeutics Announces $280 Mln Direct Offering Of Shares At $71.50/Share; Stock Drops (RTTNews)
22.12.23	Our 2023 'Short-Term Investor' Winners! Did You Ride The Rally? (RTTNews)
30.11.23	Biotech Stocks Facing FDA Decision In December 2023 (RTTNews)
16.11.23	First Regulatory Authorization For A CRISPR-based Gene-editing Therapy (RTTNews)
01.11.23	Pre -market Movers: CLLS, PAYC, WE, IRIX, GDEV… (RTTNews)
07.09.23	CRISPR Therapeutics: Rodger Novak To Step Down As President And Chairman (RTTNews)
27.03.23	Vertex Pharma Inks Licensing Agreement To Use CRISPR Therapeutics' Gene Editing Technology (RTTNews)
05.01.23	Pre-market Movers: OBLG, HKD, NUWE, RNER, ARCK… (RTTNews)
28.09.22	CRISPR Therapeutics Says FDA Grants RMAT Designation To CTX130 (RTTNews)
14.10.21	CRISPR Therapeutics Names Brendan Smith To Succeed Michael Tomsicek As CFO - Quick Facts (RTTNews)
13.10.21	Pre-market Movers: WTRH, NEW, RGLS, KOSS, PROC… (RTTNews)
12.07.21	Nkarta - Engineering NK Cells (RTTNews)
04.12.20	FDA Nod For BCRX - Decision In Japan, Europe Next, ENLV Soars On COVID Trial Data, STRO Abuzz (RTTNews)
05.11.20	BIIB Faces FDA Panel Tomorrow, CRSP Climbs On Hemoglobinopathies Trial Data, SAVA On Watch (RTTNews)
22.10.20	CRSP Reports CARBON Trial Data, NK's COVID-19 Vaccine Study Chugs Along, ZSAN Slips As FDA Says "No" (RTTNews)
21.10.20	Stock Alert: CRISPR Therapeutics Down 10% (RTTNews)
21.10.20	CRISPR Reports Positive Top-Line Results From Phase 1 Trial Of CTX110 - Quick Facts (RTTNews)
08.10.20	Pre-market Movers In Healthcare Sector: CDNA, IMTX, REGN, CRSP, TLC... (RTTNews)
13.02.20	Stock To Watch: CRISPR Therapeutics (CRSP) (RTTNews)
22.11.19	CRSP Prices Offering At $64.50/Share (RTTNews)
19.11.19	Healthcare Stocks That Hit New Highs (XBIT, DRNA, CRSP...) (RTTNews)
11.10.18	CRISPR Therapeutics Pulls Back Off Best Levels But Remains Firmly Positive (RTTNews)
11.10.18	ACRX Nears D-day, TRVN On Watch, All's Well With CRSP, TearLab Disappointed (RTTNews)
03.06.18	An Ear To The Pharma: 9 Stocks To Watch (CTMX, ZEAL, MRSN...) (RTTNews)
31.05.18	CRSP Falls On Clinical Hold, PFE Gets FDA Nod, ARWR To Report Data In Nov. (RTTNews)
06.04.18	A Glance At Potential Therapies For Sickle Cell Disease (RTTNews)
09.02.18	FDA Nod For JNJ, CORI Awaits Results In Q2, MDGL's HeFH Data Fails To Impress (RTTNews)
08.02.18	TBPH Inks $1Bln Deal, SGMO Hits Yearly High, ANAB Is Back Again (RTTNews)
30.01.18	AKCA ON The Move, MNLO Makes A Mark, OBSV Looks Ahead With Hope, ARGX Soars (RTTNews)
12.01.18	PRTO On The Move, ARWR Hits A High, WVE Doesn't Wane, Big Events Await CHRS (RTTNews)
12.12.17	Vertex, CRISPR Therapeutics To Co-develop And Co-commercialize CTX001 (RTTNews)
11.08.17	ACHV Soars On New Achievement, AEZS Shrinks Q2 Loss, TXMD On Watch (RTTNews)
20.04.17	Gainers & Losers Of Apr.19: SNGX, IMGN, CBLI, SSH, AKTX... (RTTNews)
29.03.17	Gainers & Losers Of Mar.28: CBIO, AKER, IMMY, HTGM, PAVM... (RTTNews)
01.03.17	Gainers & Losers Of Feb.28: KITE, PBMD, LIFE, VRX, PRGO... (RTTNews)
17.02.17	Gainers & Losers Of The Day: CRSP, XTLB, CRSP, ACUR, EVOK... (RTTNews)
16.02.17	ARDX Kidney Drug Passes Phase 3 Study, EDIT Up On CRISPR News, FDA Nod For VRX (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu CRISPR Therapeutics AG

Aktien Top/Flop

Meistgelesene Nachrichten